Overview
USDY vs Injective is one of the most watched crypto matchups. Beyond headline prices, this comparison blends market structure, technical readings and probabilistic context without promising outcomes.
Quick winners
Full comparison
| Metric | USDY | INJ |
|---|---|---|
| Price | $1,880.52 | $5.15 |
| Market Cap | $2.15B | $490.41M |
| FDV | — | — |
| Volume 24h | $2.11M | $2.50M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 40.00 | 98.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | USDY | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.00% | +5.19% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | USDY | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 63.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
When RSI and trend disagree across USDY and Injective, expect choppy relative performance until one side reclaims a clear structure.
Fundamentals
| Metric | USDY | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
USDY
Injective
Pros and cons
Pros of USDY
- Composite PEPS readings for USDY can surface clearer module agreement during trend phases.
- USDY often anchors narratives that attract sustained media and analyst coverage.
Cons of USDY
- Large-cap status for USDY can mean slower percentage upside versus high-beta alternatives.
- Regulatory or macro headlines can hit USDY harder simply because it is more visible.
- Crowded positioning around USDY sometimes amplifies squeeze or flush risk.
Pros of Injective
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- Active volume bursts on INJ sometimes precede sharper tactical moves.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
Cons of Injective
- Trend failures on Injective often travel faster than on more established assets.
- Smaller book depth versus large caps can increase slippage for Injective.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
Which looks stronger right now?
The “stronger” label here is descriptive, not predictive. USDY and Injective can alternate leadership as macro liquidity and narrative rotate.
AI summary
Comparing USDY and INJ begins with structure: capitalization, volume and rank. Present prints are $1,880.52 versus $5.15. Momentum and trend can disagree with market-cap hierarchy. That is normal in crypto rotations and should be stress-tested against supports and news flow. Canonical URLs prevent duplicate INJ-vs-USDY pages, keeping SEO equity on one comparison. Keep monitoring winners as data updates.
FAQ
Which is better, USDY or Injective?
“Better” depends on horizon and risk. USDY leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, USDY or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both USDY and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.